Literature DB >> 2543013

Inhibitory effect of a selective kappa receptor agonist, U-50, 488H, on methamphetamine-elicited ipsilateral circling behavior in rats with unilateral nigral lesions.

M Ohno1, T Yamamoto, S Ueki.   

Abstract

The present study was designed to investigate the effect of U-50, 488H, a highly selective kappa opioid agonist, on ipsilateral and contralateral circling behavior induced by methamphetamine and by apomorphine, respectively. U-50, 488H (3.2-10 mg/kg IP) by itself failed to induce either ipsilateral or contralateral circling in rats with unilateral nigral lesions produced by an injection of 6-hydroxydopamine. U-50, 488H produced a significant dose-dependent inhibition of methamphetamine (1.0 mg/kg SC)-elicited ipsilateral circling. However, it had no effect on contralateral circling induced by apomorphine (0.5 mg/kg SC). The present results indicate that U-50, 488H presynaptically inhibits the release of dopamine in the rat striatum.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2543013     DOI: 10.1007/bf00442253

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  25 in total

1.  Indirect activation of the DA system as a possible mechanism for the stimulatory effects of narcotic analgesics.

Authors:  G Di Chiara; L Vargiu; M L Porceddu; R Longoni; A Mulas; G L Gessa
Journal:  Adv Biochem Psychopharmacol       Date:  1977

2.  The effects of morphine- and nalorphine- like drugs in the nondependent and morphine-dependent chronic spinal dog.

Authors:  W R Martin; C G Eades; J A Thompson; R E Huppler; P E Gilbert
Journal:  J Pharmacol Exp Ther       Date:  1976-06       Impact factor: 4.030

3.  Striatal dopamine release after amphetamine or nerve degeneration revealed by rotational behaviour.

Authors:  U Ungerstedt
Journal:  Acta Physiol Scand Suppl       Date:  1971

4.  Locomotor activity and antinociception after putative mu, kappa and sigma opioid receptor agonists in the rat: influence of dopaminergic agonists and antagonists.

Authors:  E T Iwamoto
Journal:  J Pharmacol Exp Ther       Date:  1981-05       Impact factor: 4.030

5.  Effects of bremazocine on locomotor activity in DBA/2 and C57BL/6 mice.

Authors:  C Castellano; F Pavone
Journal:  Arch Int Pharmacodyn Ther       Date:  1985-11

6.  Opposite effects of mu and kappa opiates on the firing-rate of dopamine cells in the substantia nigra of the rat.

Authors:  J M Walker; L A Thompson; J Frascella; M W Friederich
Journal:  Eur J Pharmacol       Date:  1987-01-28       Impact factor: 4.432

7.  The effects of acutely administered analgesics on the turnover of noradrenaline and dopamine in various regions of the rat brain.

Authors:  M F Sugrue
Journal:  Br J Pharmacol       Date:  1974-10       Impact factor: 8.739

8.  U-50,488: a selective and structurally novel non-Mu (kappa) opioid agonist.

Authors:  P F Vonvoigtlander; R A Lahti; J H Ludens
Journal:  J Pharmacol Exp Ther       Date:  1983-01       Impact factor: 4.030

9.  Properties of a selective kappa agonist, U-50,488H.

Authors:  R A Lahti; P F VonVoigtlander; C Barsuhn
Journal:  Life Sci       Date:  1982 Nov 15-22       Impact factor: 5.037

10.  Opposite effects of mu and kappa opiate agonists on dopamine release in the nucleus accumbens and in the dorsal caudate of freely moving rats.

Authors:  G Di Chiara; A Imperato
Journal:  J Pharmacol Exp Ther       Date:  1988-03       Impact factor: 4.030

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.